This is such a flawed comment.
This isn't a business venture. One person didn't set up this company and hold 50% all the way through.
It's a publicly listed company trying to help children.
It's what these guys do. Sure, they might have other degrees and other experience. But they work in the health care sector.
There is no reason to take any money off the table. Unless they wish to retire.
And I dont believe that to be the case.
I must admit that I found valuations of $876 (or whatever it was to be ludicrous)
But I also feel the same about $30.
But in the meanwhile, stop burning cash on the buyback.
And keep doing what they do best. And that is developing world first drugs to help kids.
KPI's come in various forms.
My main 2 are leading and lagging.
If we keep doing what we do (work on leading indicators such as developing).
Then lagging (market cap or takeover) will take care of itself.
That is a perfect organic growth scenario. Theres no need to push or search for anything other than a partner to assist in the manufacture and distribution of NNZ2591.
We know we cant do this in large scale on our own.
And we have plenty of time to sort that out.
Personally, I'm not expecting any lift in the MC after the FDA meeting. Oh look, maybe 20%.
But not back to $25.
NEU Price at posting:
$12.30 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)